Rare Disease

Rare Disease Connect in Neurology (RDCN) is a long-term learning program, connecting the MG community committed to delivering excellence for patients living with myasthenia gravis (MG). Our mission is to collaborate, educate and inspire through cutting-edge science, expert insight, and lively discussion. Imagine what we can do for patients, together.​

Explore diagnostic approaches for mitochondrial myopathies through a case review. Feature Video: Dr. Michio Hirano, 2025 Muscular Dystrophy Association Conference​

Explore the evolving therapeutic landscape of generalized myasthenia gravis, with a focus on individualized treatment goals, patient perspectives, and the integration of novel agents such as FcRn and complement inhibitors. Review clinical strategies for optimizing care and the importance of shared decision-making in practice.